Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK, and PD of STG-001 in Stargardt Disease
NCT04489511Phase 2Completed
- Sponsor
- Stargazer Pharmaceuticals
- Start
- Oct 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of STG-001 in Stargardt disease (STGD), sponsored by Stargazer Pharmaceuticals. Started Oct 2020; status: completed.
02
Drugs
STG-001
03
Conditions
Stargardt disease (STGD)
Beyond the preview
Go deeper on NCT04489511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04489511.